Hypertension in hemodialysis patients treated with atenolol or lisinopril: a randomized controlled trial | Zendy

Rajiv Agarwal | Zendy; Arjun Sinha | Zendy; Maria K. Pappas | Zendy; Terri N. Abraham | Zendy; Getachew G. Tegegne | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Hypertension in hemodialysis patients treated with atenolol or lisinopril: a randomized controlled trial

Author(s) -

Rajiv Agarwal,

Arjun Sinha,

Maria K. Pappas,

Terri N. Abraham,

Getachew G. Tegegne

Publication year - 2014

Publication title -

nephrology dialysis transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.654

H-Index - 168

eISSN - 1460-2385

pISSN - 0931-0509

DOI - 10.1093/ndt/gft515

Subject(s) - medicine , lisinopril , atenolol , left ventricular hypertrophy , hemodialysis , cardiology , ace inhibitor , randomized controlled trial , muscle hypertrophy , blood pressure , angiotensin converting enzyme

The purpose of this study was to determine among maintenance hemodialysis patients with echocardiographic left ventricular hypertrophy and hypertension whether in comparison with a β-blocker-based antihypertensive therapy, an angiotensin converting enzyme-inhibitor-based antihypertensive therapy causes a greater regression of left ventricular hypertrophy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research